Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 1170

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 1170
---
. Departures
of our management team and board members have created, and will create if they continue, significant continuity risks and challenges to
our ability to operate our business, assess and manage risks and comply with applicable laws. If key members of our senior management
team depart, it will be important that we attract and retain qualified managers promptly and develop and implement an effective succession
plan. We expect to face significant competition in attracting experienced executives and other key personnel, and there can be no assurance
that we will be able to do so. Further, to the extent we experience additional management turnover, competition for top management is
high and it may take months to find a candidate that meets our requirements. If we are unable to attract and retain qualified management
personnel, our business could suffer.

We also
experience competition for the hiring of scientific and clinical personnel from universities and research institutions. Further, inflationary
pressure may increase our costs, including employee compensation costs or result in employee attrition to the extent our compensation
does not keep up with inflation, particularly if our competitors’ compensation does.

Renovaro
Cube and BioSymetrics are highly dependent on their key personnel. If Renovaro Cube or BioSymetrics is not successful in attracting, motivating
and retaining highly qualified personnel, they may not be able to successfully implement their business strategy.

Renovaro
Cube’s and BioSymetrics’ ability to compete in the highly competitive AI-driven healthcare technology industry depends upon
its ability to attract, motivate and retain highly qualified personnel. We are highly dependent on our executive management team and its
scientific, medical, technological and engineering personnel, all of whom have been working together as a group for only a limited period
of time. The loss of the services provided by any of our executive officers, other key employees and other scientific and medical advisors,
and our inability to find suitable replacements as needed, could result in delays in commercialization of its products and harm our business.
Renovaro Cube and BioSymetrics do not maintain “key person” insurance policies on the lives of these individuals or the lives
of any of their other employees.

Renovaro
Cube is headquartered in Amsterdam, the Netherlands, a region in which many other healthcare companies, technology companies and academic
and research institutions are headquartered. Competition for personnel is intense and the turnover rate can be high, which may limit Renovaro
Cube’s ability to hire and retain highly qualified personnel on acceptable terms or at all. Renovaro Cube expects that it may need